Cholangiocarcinoma and Gallbladder Cancer Studies
Cholangiocarcinoma and Gallbladder Cancer Studies is a research topic within Surgery. Science Explorer counts 39k research works in it since 1950. 16.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis, management, epidemiology, and therapeutic strategies for cholangiocarcinoma, including intrahepatic and hilar cholangiocarcinoma. It covers topics such as surgical management, molecular pathology, and prognostic factors. The papers also discuss the increasing incidence and mortality of biliary tract cancers, as well as emerging targeted therapies.
- Cholangiocarcinoma
- Biliary Tract Cancer
- Intrahepatic Cholangiocarcinoma
- Hilar Cholangiocarcinoma
- Gallbladder Cancer
- Epidemiology
- Therapeutic Strategies
- Molecular Pathology
- Surgical Management
- Prognostic Factors
- Research works
- 39k fractional, since 1950
- In the world top 10%
- 6.2k per year above
- Top-10% rate
- 16.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +36% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Cholangiocarcinoma and Gallbladder Cancer Studies research?
By volume, China and the United States publish the most (2.3k and 1.4k works in 2022–2025).
By volume, 2022–2025
- 1 China 2.3k works
- 2 United States 1.4k works
- 3 Japan 834 works
- 4 South Korea 404 works
- 5 India 389 works
- 6 Italy 319 works
- 7 Germany 259 works
- 8 United Kingdom 252 works
- 9 France 169 works
- 10 Spain 138 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cholangiocarcinoma and Gallbladder Cancer Studies research?
By volume in 2022–2025, Sun Yat-sen University publishes the most Cholangiocarcinoma and Gallbladder Cancer Studies research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Sichuan University.
By volume, 2022–2025
- 1 Sun Yat-sen UniversityChina 69 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 49 works
- 3 Sichuan UniversityChina 48 works
- 4 The University of Texas MD Anderson Cancer CenterUnited States 46 works
- 5 West China Hospital of Sichuan UniversityChina 36 works
- 6 Memorial Sloan Kettering Cancer CenterUnited States 33 works
- 7 Khon Kaen UniversityThailand 32 works
- 8 The Ohio State University Wexner Medical CenterUnited States 31 works
- 9 Second Military Medical UniversityChina 30 works
- 10 Nanjing Medical UniversityChina 30 works
Who are the leading researchers in Cholangiocarcinoma and Gallbladder Cancer Studies?
The most-cited researchers publishing on Cholangiocarcinoma and Gallbladder Cancer Studies include Jordi Bruix.
- 1 Jordi Bruix Spain 3.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cholangiocarcinoma and Gallbladder Cancer Studies research done?
The largest centres of Cholangiocarcinoma and Gallbladder Cancer Studies research in 2022–2025 are Beijing (China), Shanghai (China), Seoul (South Korea) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Khon Kaen, Rozzano and Shizuoka.
Largest cities, 2022–2025
Where it is the local speciality
- Khon KaenTH · 32.5 works19×
- RozzanoIT · 20.9 works18×
- ShizuokaJP · 25.4 works16×
Location quotient: how much more of its research is in Cholangiocarcinoma and Gallbladder Cancer Studies than the world average.
Where is the best place to study Cholangiocarcinoma and Gallbladder Cancer Studies?
Among universities, judged by research, Humanitas University, Vita-Salute San Raffaele University and Khon Kaen University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Humanitas UniversityItaly | 70.6 | 29.7% | 18.2× | 11 | +338.2% |
| 2 | Vita-Salute San Raffaele UniversityItaly | 62.3 | 26.0% | 11.5× | 11 | +118.6% |
| 3 | Khon Kaen UniversityThailand | 61.7 | 22.4% | 19.7× | 32 | +23.8% |
| 4 | University of VeronaItaly | 61.6 | 21.3% | 11.2× | 20 | +101.9% |
| 5 | Sun Yat-sen UniversityChina | 59.7 | 23.8% | 5.8× | 69 | +56.4% |
| 6 | Fujian Medical UniversityChina | 58.9 | 25.5% | 9.1× | 24 | +47.6% |
| 7 | Second Military Medical UniversityChina | 58.6 | 23.6% | 34.3× | 30 | -3.8% |
| 8 | Nanjing Medical UniversityChina | 55.9 | 18.9% | 7.8× | 30 | +110.3% |
| 9 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 54.3 | 21.9% | 6.7× | 48 | +14.1% |
| 10 | Zhejiang Chinese Medical UniversityChina | 53.5 | 34.1% | 6.6× | 13 | — |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cholangiocarcinoma and Gallbladder Cancer Studies research growing?
Output in 2018–2022 was 36% higher than in 2013–2017, peaking in 2022. The fastest-growing topics are Cholangiocarcinoma and Gallbladder Cancer Studies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.